Has Robin Carson received payments from drug or device companies?

Yes. Drug and device makers reported $7,386 in general payments to Robin Carson across 425 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Robin Carson did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Robin Carson come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Robin Carson

Obstetrics & Gynecology · Tulsa, OKNPI 1508820903

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.4% of the total across 425 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 40 manufacturers reported payments, led by AbbVie at 26.9% of the total. Among obstetrics & gynecology clinicians in OK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,386in general payments, 2019–2025

Across 425 payments — averaging $17.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$2K
Mayne Pharma Commercial LLC$934
Astellas Pharma US Inc$668
Novo Nordisk$453
Agile Therapeutics, Inc.$442
Therapeuticsmd, Inc.$361
plus $3K from 34 others

What the payments were for

Food & beverage$7,27098%
Education$1162%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	111	$1,984
Mayne Pharma Commercial LLC	66	$934
Astellas Pharma US Inc	30	$668
Novo Nordisk	34	$453
Agile Therapeutics, Inc.	21	$442
Therapeuticsmd, Inc.	26	$361
Sumitomo Pharma America, Inc.	17	$336
Exeltis, USA Inc.	17	$331
Millicent US Inc	15	$282
Currax Pharmaceuticals LLC	14	$193
Evofem Biosciences, Inc.	10	$130
Minerva Surgical, Inc	3	$109
Organon	7	$100
Pfizer	5	$96
Mylan Pharmaceuticals Inc.	4	$71
Roche Diagnostics Corporation	4	$71
Si-bone, Inc.	1	$62
Sage Therapeutics, LLC	3	$56
Lilly USA, LLC	4	$55
Daiichi Sankyo Inc.	3	$52
Hologic Sales And Service, LLC	2	$44
Coopersurgical, Inc.	2	$43
Aspira Women's Health Inc	1	$43
Myovant Sciences Inc.	2	$42
Exact Sciences	2	$41
Takeda Pharmaceuticals U.S.A., Inc.	2	$38
Avion Pharmaceuticals	2	$37
Kowa Pharmaceuticals America, Inc.	2	$37
Intra-sana Laboratories	2	$33
Lupin Inc.	2	$32
Biohaven Pharmaceuticals, Inc.	2	$29
Vertex	1	$27
Dexcom, Inc.	1	$25
Bayer	1	$23
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$21
Biohaven Pharmaceutical Holding Company Ltd.	1	$19
Supernus Pharmaceuticals, Inc.	1	$18
Mission Pharmacal Company	1	$17
AMAG Pharmaceuticals, Inc.	1	$16
Boston Scientific	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

NEXTSTELLIS$125
Orilissa$124

How this compares

$7,386 in reported general payments places this provider in the 90th percentile of 396 obstetrics & gynecology providers in Oklahoma.

See all obstetrics & gynecology providers in Oklahoma →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Estradiol	20	$1,696

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Tulsa

Joseph NemcokTulsa$632K
Jay WilliamsonTulsa$130K
Lori HubbardTulsa$41K
Micah RelicTulsa$20K
Bryan RoehlTulsa$15K
Timmeni StevensTulsa$14K
Rachel GibbsTulsa$12K
Thomas LaneTulsa$11K
Carlos GuevaraTulsa$11K
David CameronTulsa$10K

See the full list for Oklahoma →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →